[go: up one dir, main page]

NO20011863L - Nye cyklobutaindolkarboksamidforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem - Google Patents

Nye cyklobutaindolkarboksamidforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem

Info

Publication number
NO20011863L
NO20011863L NO20011863A NO20011863A NO20011863L NO 20011863 L NO20011863 L NO 20011863L NO 20011863 A NO20011863 A NO 20011863A NO 20011863 A NO20011863 A NO 20011863A NO 20011863 L NO20011863 L NO 20011863L
Authority
NO
Norway
Prior art keywords
cyclobuta
preparation
new
methods
pharmaceutical compositions
Prior art date
Application number
NO20011863A
Other languages
English (en)
Other versions
NO20011863D0 (no
NO318206B1 (no
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Francoise Lejeune
Didier Cussac
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20011863D0 publication Critical patent/NO20011863D0/no
Publication of NO20011863L publication Critical patent/NO20011863L/no
Publication of NO318206B1 publication Critical patent/NO318206B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20011863A 2000-04-13 2001-04-11 Nye cyklobutaindolkarboksamidforbindelser og farmasoytiske sammensetninger inneholdende dem NO318206B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0004743A FR2807754A1 (fr) 2000-04-13 2000-04-13 Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20011863D0 NO20011863D0 (no) 2001-04-11
NO20011863L true NO20011863L (no) 2001-10-15
NO318206B1 NO318206B1 (no) 2005-02-14

Family

ID=8849213

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011863A NO318206B1 (no) 2000-04-13 2001-04-11 Nye cyklobutaindolkarboksamidforbindelser og farmasoytiske sammensetninger inneholdende dem

Country Status (24)

Country Link
US (2) US6452015B2 (no)
EP (1) EP1146044B1 (no)
JP (1) JP3396675B2 (no)
KR (1) KR100470691B1 (no)
CN (1) CN1323796A (no)
AR (1) AR042379A1 (no)
AT (1) ATE275140T1 (no)
AU (1) AU779366B2 (no)
BR (1) BR0101466A (no)
CA (1) CA2344108C (no)
DE (1) DE60105219T2 (no)
DK (1) DK1146044T3 (no)
EA (1) EA004738B1 (no)
ES (1) ES2227082T3 (no)
FR (1) FR2807754A1 (no)
HK (1) HK1040247A1 (no)
HU (1) HUP0101504A3 (no)
NO (1) NO318206B1 (no)
NZ (1) NZ511091A (no)
PL (1) PL347046A1 (no)
PT (1) PT1146044E (no)
SI (1) SI1146044T1 (no)
TR (1) TR200402685T4 (no)
ZA (1) ZA200103064B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2837823B1 (fr) * 2002-03-27 2005-04-08 Servier Lab Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2933975B1 (fr) * 2008-07-17 2011-02-18 Servier Lab Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
KR20220029900A (ko) * 2020-09-02 2022-03-10 에스케이하이닉스 주식회사 버퍼 회로

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4704693A (en) * 1992-08-20 1994-03-15 Smithkline Beecham Plc Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists
GB9306460D0 (en) * 1993-03-29 1993-05-19 Smithkline Beecham Plc Novel compounds
JPH09512025A (ja) * 1994-04-23 1997-12-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5ht▲下2c▼および5ht▲下2b▼アンタゴニストとしての三環式誘導体
KR19980701879A (ko) * 1995-02-02 1998-06-25 피터 기딩스 5-히드록시트립타민 수용체 길항제로서의 인돌 유도체
CA2195346C (en) * 1995-12-21 2007-04-10 Zhi Yuan Wang Benzocyclobutenones and polymers derived therefrom
DE69931042T2 (de) * 1998-02-27 2006-11-23 The Board Of Trustees Of The University Of Illinois, Urbana Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe

Also Published As

Publication number Publication date
ES2227082T3 (es) 2005-04-01
NZ511091A (en) 2001-09-28
DE60105219T2 (de) 2005-09-15
EA200100344A2 (ru) 2001-10-22
US6743818B2 (en) 2004-06-01
CA2344108C (fr) 2005-11-29
US20010044426A1 (en) 2001-11-22
AU3518601A (en) 2001-10-18
HK1040247A1 (zh) 2002-05-31
KR100470691B1 (ko) 2005-03-07
PL347046A1 (en) 2001-10-22
ZA200103064B (en) 2001-10-18
US20030032812A1 (en) 2003-02-13
EA200100344A3 (ru) 2002-02-28
KR20010098581A (ko) 2001-11-08
CN1323796A (zh) 2001-11-28
AR042379A1 (es) 2005-06-22
JP3396675B2 (ja) 2003-04-14
EP1146044B1 (fr) 2004-09-01
DK1146044T3 (da) 2004-12-27
AU779366B2 (en) 2005-01-20
CA2344108A1 (fr) 2001-10-13
JP2001302661A (ja) 2001-10-31
HUP0101504A2 (hu) 2002-02-28
BR0101466A (pt) 2001-12-11
SI1146044T1 (en) 2004-12-31
EP1146044A1 (fr) 2001-10-17
ATE275140T1 (de) 2004-09-15
FR2807754A1 (fr) 2001-10-19
NO20011863D0 (no) 2001-04-11
US6452015B2 (en) 2002-09-17
PT1146044E (pt) 2004-11-30
TR200402685T4 (tr) 2004-11-22
HUP0101504A3 (en) 2002-11-28
HU0101504D0 (en) 2001-06-28
DE60105219D1 (de) 2004-10-07
NO318206B1 (no) 2005-02-14
EA004738B1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
NO996250D0 (no) Nye hydrazidforbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
NO20021599D0 (no) Nye farmasöytiske sammensetninger av anti-tuberkulose legemidler og fremgangsmåte for deres fremstilling
NO20013254L (no) Nye difenylureaforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske samensetninger som inneholder dem
DK1263721T3 (da) Farmaceutiske sammensætninger, der indeholder 3-aminoazetidinderivater, nye derivater og fremstilling deraf
NO20023319D0 (no) Substituerte glutarimider og deres anvendelse som inhibitorer av IL-12-produksjonen
NO20030298L (no) Nye heteroarylderivater og deres anvendelse som farmasöytiske midler
NO20003764D0 (no) Nye <beta>-karbolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO20042805L (no) Nye forbindelser og deres anvendelse innen medisin, fremgangsmate for deres fremstilling og farmaoytiske sammensetninger som inneholder dem
NO20023400D0 (no) Nye forbindelser med lipid- og kolesterolnedsettende virkning, fremgangsmåte ved deres fremstilling og farmasöytiskpreparat
NO20010522L (no) Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20026154D0 (no) Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023662L (no) Nye heterocykliske derivater, fremgangsmåte ved fremstilling og farmasöytiske sammensetninger inneholdende det samme
NO20030382D0 (no) Nye indolderivater og deres anvendelse som medikamenter
NO20014945L (no) Nye cyklonbutendionforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
IS7008A (is) Nýjar píperidínkarboxamíð afleiður, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þær
NO20013206L (no) Nye 1,1- og 1,2-disubstituerte cyklopropanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem
NO20021330L (no) Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021198L (no) Nye isoindoloindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20011863D0 (no) Nye cyklobutaindolkarboksamidforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20031643D0 (no) Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20016069D0 (no) Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20013710D0 (no) Nye benzotiadiazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023389D0 (no) Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023409D0 (no) Nye N-benzylpiperazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20022794L (no) Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem